Whiting RL - Search Results

1

Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivo.

Eglen RM, Lee CH, Smith WL, Johnson LG, Clark R, Whiting RL, Hegde SS. Eglen RM, et al. Among authors: whiting rl. Br J Pharmacol. 1995 Feb;114(4):860-6. doi: 10.1111/j.1476-5381.1995.tb13283.x. Br J Pharmacol. 1995. PMID: 7773547 Free PMC article.

2

Desensitization and functional antagonism by beta-adrenoceptor and muscarinic receptor agonists, respectively: a comparison with receptor alkylation for calculation of apparent agonist affinity.

Eglen RM, Montgomery WW, Whiting RL. Eglen RM, et al. Among authors: whiting rl. Br J Pharmacol. 1991 Aug;103(4):1951-7. doi: 10.1111/j.1476-5381.1991.tb12358.x. Br J Pharmacol. 1991. PMID: 1680517 Free PMC article.

3

Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.

Sharif NA, Wong EH, Loury DN, Stefanich E, Michel AD, Eglen RM, Whiting RL. Sharif NA, et al. Among authors: whiting rl. Br J Pharmacol. 1991 Apr;102(4):919-25. doi: 10.1111/j.1476-5381.1991.tb12277.x. Br J Pharmacol. 1991. PMID: 1830236 Free PMC article.

4

Pharmacological profile of the dopamine agonist, RS-45946.

Rosenkranz RP, Caroon JM, Clark RD, Eglen RM, Fisher LE, McClelland DL, Michel AD, Muchowski JM, Whiting RL. Rosenkranz RP, et al. Among authors: whiting rl. Proc West Pharmacol Soc. 1990;33:37-43. Proc West Pharmacol Soc. 1990. PMID: 1980364 Review. No abstract available.

5

Characterization of 5-HT3 and 'atypical' 5-HT receptors mediating guinea-pig ileal contractions in vitro.

Eglen RM, Swank SR, Walsh LK, Whiting RL. Eglen RM, et al. Among authors: whiting rl. Br J Pharmacol. 1990 Nov;101(3):513-20. doi: 10.1111/j.1476-5381.1990.tb14113.x. Br J Pharmacol. 1990. PMID: 2076474 Free PMC article.

6

Characterization of the muscarinic receptor subtype mediating contractions of the guinea-pig uterus.

Eglen RM, Michel AD, Whiting RL. Eglen RM, et al. Among authors: whiting rl. Br J Pharmacol. 1989 Mar;96(3):497-9. doi: 10.1111/j.1476-5381.1989.tb11843.x. Br J Pharmacol. 1989. PMID: 2497919 Free PMC article.

7

Characterization of the prostanoid receptor profile of enprostil and isomers in smooth muscle and platelets in vitro.

Eglen RM, Whiting RL. Eglen RM, et al. Among authors: whiting rl. Br J Pharmacol. 1989 Dec;98(4):1335-43. doi: 10.1111/j.1476-5381.1989.tb12682.x. Br J Pharmacol. 1989. PMID: 2514950 Free PMC article.

8

The pharmacological properties of the peptide, endothelin.

Eglen RM, Michel AD, Sharif NA, Swank SR, Whiting RL. Eglen RM, et al. Among authors: whiting rl. Br J Pharmacol. 1989 Aug;97(4):1297-307. doi: 10.1111/j.1476-5381.1989.tb12592.x. Br J Pharmacol. 1989. PMID: 2551446 Free PMC article.

9

RS-61756-007: a potent and selective thromboxane receptor (TP) agonist.

Eglen RM, Whiting RL. Eglen RM, et al. Among authors: whiting rl. J Pharm Pharmacol. 1989 May;41(5):347-9. doi: 10.1111/j.2042-7158.1989.tb06472.x. J Pharm Pharmacol. 1989. PMID: 2569526

10

The action of prostanoid receptor agonists and antagonists on smooth muscle and platelets.

Eglen RM, Whiting RL. Eglen RM, et al. Among authors: whiting rl. Br J Pharmacol. 1988 Jun;94(2):591-601. doi: 10.1111/j.1476-5381.1988.tb11565.x. Br J Pharmacol. 1988. PMID: 3134971 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters